Jason T Hindman

10PUBLICATIONS
26CO-AUTHORS
Gene and molecular therapyRespiratory diseasesHaematologyCharacterisation of biological macromoleculesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 17, 2026
B/F/TAF in people with both HIV-1 and hepatitis B: outcomes from the ALLIANCE open-label extension phase.

|May 25, 2026
Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials.

|Feb 13, 2026
Risk of hypertension in people with HIV in the USA initiating modern antiretroviral regimens: pooled analysis of blood pressure data from five clinical trials.

Priscilla Y Hsue, Laura Waters, Chloe Orkin

|Nov 28, 2025
The effect of antacid and mineral supplements on bictegravir pharmacokinetics: results from a Phase 1, open-label, drug-drug interaction study.

Priyanka Arora, Jason T Hindman, Steve West

|Oct 14, 2025
Integrated Population Pharmacokinetic-pharmacodynamic Modeling of HIV Virus-host Infection Dynamics in Patients Undergoing Antiretroviral Monotherapy.

Alberto Vegas Rodriguez, Nieves Velez de Mendizábal, Yanan Zheng

|Aug 26, 2025
Brief Report: HIV-1 Resistance Analysis of Participants With HIV-1 and Hepatitis B Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide or Dolutegravir Plus Emtricitabine/Tenofovir Disoproxil Fumarate Through the Open-Label Extension of the ALLIANCE Study.

Michelle L D'Antoni, Archana V Boopathy, Kristen Andreatta

Pageof 2

Frequent Collaborators

2 joint publications

Priyanka Arora

2 joint publications

Dhananjay D Marathe

2 joint publications

Anchalee Avihingsanon

2 joint publications

Keith Aizen